UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

P.1.j.009 Breaking evidence from a human object pattern separation test of disrupted hippocampal dentate gyrus activity in schizophrenics

European neuropsychopharmacology, 2013-10, Vol.23, p.S286-S286

Wesnes, K

2013

Volltextzugriff (PDF)

P.5.b.004 Object pattern separation performance in Alzheimer's patients links compromised hippocampal neurogenesis to APOE4 status and CSF Aβ42

European neuropsychopharmacology, 2013-10, Vol.23, p.S541-S542

Wesnes, K

2013

Volltextzugriff (PDF)

Is there a relationship between low-grade systemic inflammation and cognition in healthy people aged 60–75 years?

Behavioural brain research, 2020-04, Vol.383, p.112502-112502, Article 112502

2020

Volltextzugriff (PDF)

P.5.a.001 A comparison of traditional neuropsychological tests and automated cognitive tests in assessing cognitive decline in the elderly

European neuropsychopharmacology, 2012-10, Vol.22, p.S381-S381

Wesnes, K

2012

Volltextzugriff (PDF)

P.5.a.002 Validation of an internet based instrument for assessing cognitive function

European neuropsychopharmacology, 2012-10, Vol.22, p.S382-S382

Wesnes, K

2012

Volltextzugriff (PDF)

P.7.d.006 Differential effects on attention over 24 weeks of an NMDA antagonist versus carbamazepine in paediatric epilepsy patients

European neuropsychopharmacology, 2013-10, Vol.23, p.S602-S602

2013

Volltextzugriff (PDF)

P.2.b.009 Effects of levomilnacipran ER on measures of attention in a phase III trial of major depressive disorder

European neuropsychopharmacology, 2014-10, Vol.24, p.S383-S383

2014

Volltextzugriff (PDF)

P.1.g.015 Is neurogenesis in the dentate gyrus compromised in Parkinson's disease?

European neuropsychopharmacology, 2012-10, Vol.22, p.S213-S213

2012

Volltextzugriff (PDF)

P.1.g.003 The effects of chronic lower back pain on cognitive function

European neuropsychopharmacology, 2012-10, Vol.22, p.S206-S207

2012

Volltextzugriff (PDF)

P.2.b.031 Differences in memory function between 5-HT1A genotypes in patients with major depressive disorder

European neuropsychopharmacology, 2013-10, Vol.23, p.S337-S337

2013

Volltextzugriff (PDF)

Evaluation of drug–drug interactions of sodium oxybate with diclofenac: Results from a pharmacokinetic/pharmacodynamic study

Sleep medicine, 2013-12, Vol.14, p.e115-e115

2013

Volltextzugriff (PDF)

P.1.g.014 Automated tests of attention and information processing as an alternative to the Paced Auditory Serial Addition Test (PASAT) in clinical trials in multiple sclerosis

European neuropsychopharmacology, 2012-10, Vol.22, p.S212-S213

2012

Volltextzugriff (PDF)

Safety and efficacy of ORM-12741 on cognitive and behavioral symptoms in patients with Alzheimer's disease: A randomized, double-blind, proof-of-concept study

Journal of the neurological sciences, 2013-10, Vol.333, p.e322-e322

2013

Volltextzugriff (PDF)

PMH12 THE PROFILE OF IMPAIRMENTS TO ATTENTION AND EPISODIC RECOGNITION MEMORY IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE

Value in health, 2011, Vol.14 (3), p.A187-A187

2011

Volltextzugriff (PDF)

Evaluation of drug–drug interactions of sodium oxybate with divalproex: Results from a pharmacokinetic/pharmacodynamic study

Sleep medicine, 2013-12, Vol.14, p.e302-e303

2013

Volltextzugriff (PDF)

PND63 LITTLE OR NO TREATMENT EFFECT? APPLICATION OF GROWTH MIXTURE MODELS TO EXPLORE UNKNOWN SUBGROUPS OF DIFFERENTIAL RESPONDERS TO TREATMENT

Value in health, 2011, Vol.14 (3), p.A213-A213

2011

Volltextzugriff (PDF)

P.3.a.019 Validation of an automated rule switching test of executive function

European neuropsychopharmacology, 2012-10, Vol.22, p.S314-S315

2012

Volltextzugriff (PDF)

Investigating the relationship between age of onset of depressive disorder and cognitive function

International journal of geriatric psychiatry, 2019-01, Vol.34 (1), p.38-46

2019

Volltextzugriff (PDF)

P.1.g.021 Comparison of AChE inhibition/5-HT1A blockade in healthy subjects in a scopolamine model of cognitive impairment

European neuropsychopharmacology, 2010, Vol.20, p.S320-S320

2010

Volltextzugriff (PDF)

174 FUNCTIONAL CORE MODULATION FOLLOWING TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY WITH L-ORNITHINE L-ASPARTATE: A POTENTIAL NOVEL MECHANISM OF ACTION

Journal of hepatology, 2011-03, Vol.54, p.S74-S75

2011

Volltextzugriff (PDF)

Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults

The American journal of geriatric psychiatry, 2019-08, Vol.27 (8), p.823-834

2019

Volltextzugriff (PDF)

P.1.j.012 - Changes in EEG markers by TAK-063 in subjects with stable schizophrenia have different temporal relationships with changes in working memory

European neuropsychopharmacology, 2017-10, Vol.27, p.S728-S729

2017

Volltextzugriff (PDF)

Changes in EEG markers by TAK-063 in subjects with stable schizophrenia have different temporal relationships with changes in working memory

European neuropsychopharmacology, 2017-10, Vol.27, p.S728-S729

2017

Volltextzugriff (PDF)

Caffeine at levels found in decaffeinated beverages is behaviourally active

Appetite, 2008-03, Vol.50 (2), p.559-559

2008

Volltextzugriff (PDF)

PK/PD modeling of the interaction between IV scopolamine (SCP) and physostigmine (PHY) in healthy elderly volunteers

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P2-P2

2005

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Psychiatry
(20)
Biological And Medical Sciences
(16)
Science & Technology
(16)
Internal Medicine
(15)
Life Sciences & Biomedicine
(15)
Medical Sciences
(15)
Neurology
(14)
Dementia
(8)
Psychology. Psychoanalysis. Psychiatry
(8)
Alzheimer's Disease
(7)
Neurosciences & Neurology
(7)
Pharmacology. Drug Treatments
(7)
Cognition & Reasoning
(6)
Cognitive Ability
(6)
Clinical Neurology
(5)
Geriatrics & Gerontology
(5)
Gerontology
(5)
Medicin Och Hälsovetenskap
(5)
Neuropharmacology
(5)
Neurosciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P.1.j.009 Breaking evidence from a human object pattern separation test of disrupted hippocampal dentate gyrus activity in schizophrenics

P.5.b.004 Object pattern separation performance in Alzheimer's patients links compromised hippocampal neurogenesis to APOE4 status and CSF Aβ42

Is there a relationship between low-grade systemic inflammation and cognition in healthy people aged 60–75 years?

P.5.a.001 A comparison of traditional neuropsychological tests and automated cognitive tests in assessing cognitive decline in the elderly

P.5.a.002 Validation of an internet based instrument for assessing cognitive function

P.7.d.006 Differential effects on attention over 24 weeks of an NMDA antagonist versus carbamazepine in paediatric epilepsy patients

P.2.b.009 Effects of levomilnacipran ER on measures of attention in a phase III trial of major depressive disorder

P.1.g.015 Is neurogenesis in the dentate gyrus compromised in Parkinson's disease?

P.1.g.003 The effects of chronic lower back pain on cognitive function

P.2.b.031 Differences in memory function between 5-HT1A genotypes in patients with major depressive disorder

Evaluation of drug–drug interactions of sodium oxybate with diclofenac: Results from a pharmacokinetic/pharmacodynamic study

P.1.g.014 Automated tests of attention and information processing as an alternative to the Paced Auditory Serial Addition Test (PASAT) in clinical trials in multiple sclerosis

Safety and efficacy of ORM-12741 on cognitive and behavioral symptoms in patients with Alzheimer's disease: A randomized, double-blind, proof-of-concept study

PMH12 THE PROFILE OF IMPAIRMENTS TO ATTENTION AND EPISODIC RECOGNITION MEMORY IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE

Evaluation of drug–drug interactions of sodium oxybate with divalproex: Results from a pharmacokinetic/pharmacodynamic study

PND63 LITTLE OR NO TREATMENT EFFECT? APPLICATION OF GROWTH MIXTURE MODELS TO EXPLORE UNKNOWN SUBGROUPS OF DIFFERENTIAL RESPONDERS TO TREATMENT

P.3.a.019 Validation of an automated rule switching test of executive function

Investigating the relationship between age of onset of depressive disorder and cognitive function

P.1.g.021 Comparison of AChE inhibition/5-HT1A blockade in healthy subjects in a scopolamine model of cognitive impairment

174 FUNCTIONAL CORE MODULATION FOLLOWING TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY WITH L-ORNITHINE L-ASPARTATE: A POTENTIAL NOVEL MECHANISM OF ACTION

Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults

P.1.j.012 - Changes in EEG markers by TAK-063 in subjects with stable schizophrenia have different temporal relationships with changes in working memory

Changes in EEG markers by TAK-063 in subjects with stable schizophrenia have different temporal relationships with changes in working memory

Caffeine at levels found in decaffeinated beverages is behaviourally active

PK/PD modeling of the interaction between IV scopolamine (SCP) and physostigmine (PHY) in healthy elderly volunteers

Aktive Filter

Suchergebnisse filtern